Business & Markets · 2015-10
Valeant: The Pharmaceutical Enron?PDF Download
Andrew Left / Citron Research
Citron's report questions the relationship between Valeant and its distribution arrangements. It uses accounting concerns and comparisons with earlier corporate failures to push readers to reconsider the company's reported business.
The dramatic comparison is a rhetorical choice, not evidence by itself. Work through the specific relationships and disclosures before accepting the report's overall framing.
0.9 MB · SHA-256: 09f723cf9c7d6a9b10b563299e48b6f6c94cf1ab63eef0eb97c7d42ec216b701